Stock Earnings

Question 1

What are BioInvent International AB's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), BioInvent International AB has a total asset of $989, Net loss of $-429

Question 2

What are the key financial ratios for BOVNF?

Accepted Answer

BioInvent International AB's Current ratio is 9.6, has a Net margin is -975, sales per share of $0.66.

Question 3

How is BioInvent International AB's revenue broken down by segment or geography?

Accepted Answer

BioInvent International AB largest revenue segment is Pharmaceutical, at a revenue of 44,686,000 in the most earnings release.For geography, United States is the primary market for BioInvent International AB, at a revenue of 36,822,000.

Question 4

Is BioInvent International AB profitable?

Accepted Answer

no, according to the latest financial statements, BioInvent International AB has a net loss of $-429

Question 5

Does BioInvent International AB have any liabilities?

Accepted Answer

yes, BioInvent International AB has liability of 103

Question 6

How many outstanding shares for BioInvent International AB?

Accepted Answer

BioInvent International AB has a total outstanding shares of 65.8

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	244	44	71	326	19	147
Revenue Growth (YoY)	542%	-38%	-78%	1,616%	-87%	57.99%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	71	56	50	49	38	31
Research & Development	521	439	374	312	244	179
Operating Expenses	592	515	442	376	297	222
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-323	-429	-330	-42	-278	-76
Income Tax Expense	0	0	0	0	0	0
Net Income	-323	-429	-330	-42	-278	-76
Net Income Growth	-21%	30%	686%	-85%	266%	-45%
Shares Outstanding (Diluted)	65.93	65.8	65.76	61.52	54.16	28.71
Shares Change (YoY)	0%	0%	7%	14%	89%	56%
EPS (Diluted)	-4.91	-6.52	-5.02	-0.69	-5.14	-2.65
EPS Growth	-21%	30%	627%	-87%	93%	-65%
Free Cash Flow	-270	-390	-351	-52	-259	-69
Free Cash Flow Per Share	-4.09	-5.92	-5.33	-0.84	-4.78	-2.4
Gross Margin	--	--	--	--	--	--
Operating Margin	-142.62%	-1,070.45%	-521.12%	-15.33%	-1,463.15%	-50.34%
Profit Margin	-132.37%	-975%	-464.78%	-12.88%	-1,463.15%	-51.7%
Free Cash Flow Margin	-110.65%	-886.36%	-494.36%	-15.95%	-1,363.15%	-46.93%
EBITDA	-328	-452	-354	-36	-264	-62
EBITDA Margin	-134.42%	-1,027.27%	-498.59%	-11.04%	-1,389.47%	-42.17%
D&A For EBITDA	20	19	16	14	14	12
EBIT	-348	-471	-370	-50	-278	-74
EBIT Margin	-142.62%	-1,070.45%	-521.12%	-15.33%	-1,463.15%	-50.34%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

BioInvent International AB (BOVNF) Price

BOVNF Stock Price Chart

BOVNF Income

Follow-Up Questions